---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-033261"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T07:13:46.195571+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ProKidney closes on $25.5M purchase of 210,000 sq ft Greensboro facility for REACT manufacturing

## Summary
- Paid ~$25.5M cash for 210,000 sq ft facility and 22 acres in Greensboro, NC to support commercial production of REACT cell therapy.
- Eligible for up to $33.7M in tax credits (Greensboro, Guilford County, NC) and $1.9M in Duke Energy credits contingent on milestones.
- Must create at least 330 jobs by Dec 31, 2028 and invest ~$458M in property by Dec 31, 2027 to receive full incentives.
- Plans further investments through 2028 to prepare for potential commercial-scale manufacturing of REACT (Phase 3 for diabetic CKD).

## SEC filing metadata
- accession: 0000950170-23-033261
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000095017023033261/0000950170-23-033261-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000095017023033261/prok-20230717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-033261
- JSON: https://secwatch.observer/filing/0000950170-23-033261.json
- Plain text: https://secwatch.observer/filing/0000950170-23-033261.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.